No Data
No Data
No Data
No Data
No Data
Innote (688253.SH) announced its 2023 annual results, with net profit of 174 million yuan, an increase of 15.44%
Innote (688253.SH) released its 2023 annual report. During the reporting period, the company achieved operating income of 4...
Zhitong FinanceApr 15 04:05 ET
InnoTek's (SGX:M14) Earnings Trajectory Could Turn Positive as the Stock Rallies 18% This Past Week
Yahoo FinanceApr 14 20:15 ET
Innotek Proposes First and Final Dividend
Innotek (SGX:M14) will propose a first and final dividend of SG$0.02 at the company's annual general meeting on April 26, a company filing with the Singapore Exchange disclosed on Thursday. The divide
MT NewswiresApr 11 00:50 ET
InnoTek Limited Announces New Company Secretaries
TipRanksMar 15 07:17 ET
Innote (688253.SH): Key marketing products this year are still chromatographic products, and Jiulian products are dominated by steady growth
Gelonghui March 5 | Innote (688253.SH) disclosed an investor relations activity record table showing that this year's key marketing products are still chromatographic products, and Jiulian products are mainly growing steadily. Molecular products are expected to be launched soon. The products are positioned as routine testing items in hospitalization scenarios, and no separate equipment is required. As molecular platform technology matures, molecular POCT products are also the company's long-term plans.
Gelonghui FinanceMar 4 18:50 ET
Innote (688253.SH): At present, the product has basically achieved automated production capacity sufficient to meet sales needs
Gelonghui, March 5, 丨 Innote (688253.SH) disclosed an investor relations activity record sheet showing that at present, the company's products have basically been automated, and multiple automated production lines have been set up, and production capacity is sufficient to meet sales needs.
Gelonghui FinanceMar 4 18:49 ET
No Data
No Data